223 related articles for article (PubMed ID: 23142203)
21. Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study.
An C; Lee CH; Byun JH; Lee MH; Jeong WK; Choi SH; Kim DY; Lim YS; Kim YS; Kim JH; Choi MS; Kim MJ
Korean J Radiol; 2019 Dec; 20(12):1616-1626. PubMed ID: 31854149
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
Kim YK; Kwak HS; Han YM; Kim CS
J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
[TBL] [Abstract][Full Text] [Related]
23. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
[TBL] [Abstract][Full Text] [Related]
24. The impact of CT follow-up interval on stages of hepatocellular carcinomas detected during the surveillance of patients with liver cirrhosis.
Chung YE; Kim MJ; Park MS; Choi JY; Lim JS; Kim KA; Kim KW
AJR Am J Roentgenol; 2012 Oct; 199(4):816-21. PubMed ID: 22997373
[TBL] [Abstract][Full Text] [Related]
25. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic imaging of hepatocellular carcinoma: recent progress.
Kudo M
Oncology; 2011; 81 Suppl 1():73-85. PubMed ID: 22212940
[TBL] [Abstract][Full Text] [Related]
27. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
[TBL] [Abstract][Full Text] [Related]
28. EUS for detection of the hepatocellular carcinoma: results of a prospective study.
Singh P; Erickson RA; Mukhopadhyay P; Gopal S; Kiss A; Khan A; Ulf Westblom T
Gastrointest Endosc; 2007 Aug; 66(2):265-73. PubMed ID: 17543307
[TBL] [Abstract][Full Text] [Related]
29. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
Kim SH; Kim SH; Lee J; Kim MJ; Jeon YH; Park Y; Choi D; Lee WJ; Lim HK
AJR Am J Roentgenol; 2009 Jun; 192(6):1675-81. PubMed ID: 19457834
[TBL] [Abstract][Full Text] [Related]
30. Using low tube voltage (80kVp) quadruple phase liver CT for the detection of hepatocellular carcinoma: two-year experience and comparison with Gd-EOB-DTPA enhanced liver MRI.
Lee CH; Kim KA; Lee J; Park YS; Choi JW; Park CM
Eur J Radiol; 2012 Apr; 81(4):e605-11. PubMed ID: 22297180
[TBL] [Abstract][Full Text] [Related]
31. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
32. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
[TBL] [Abstract][Full Text] [Related]
33. Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma?
Cho Y; Lee DH; Lee YB; Lee M; Yoo JJ; Choi WM; Cho YY; Paeng JC; Kang KW; Chung JK; Yu SJ; Lee JH; Yoon JH; Lee HS; Kim YJ
PLoS One; 2014; 9(8):e105679. PubMed ID: 25153834
[TBL] [Abstract][Full Text] [Related]
34. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
35. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography.
Kakihara D; Nishie A; Harada N; Shirabe K; Tajima T; Asayama Y; Ishigami K; Nakayama T; Takayama Y; Okamoto D; Fujita N; Kishimoto J; Honda H
J Magn Reson Imaging; 2014 Nov; 40(5):1112-20. PubMed ID: 24259437
[TBL] [Abstract][Full Text] [Related]
36. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
[TBL] [Abstract][Full Text] [Related]
37. Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
Kim KA; Kim MJ; Choi JY; Park MS; Lim JS; Chung YE; Kim KW
Abdom Imaging; 2014 Apr; 39(2):291-9. PubMed ID: 24384804
[TBL] [Abstract][Full Text] [Related]
38. Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging.
Balci NC; Befeler AS; Bieneman BK; Fattahi R; Saglam S; Havlioglu N
Acad Radiol; 2009 Aug; 16(8):963-8. PubMed ID: 19386514
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up.
Furlan A; Marin D; Agnello F; Di Martino M; Di Marco V; Lagalla R; Catalano C; Brancatelli G
J Comput Assist Tomogr; 2012; 36(1):20-5. PubMed ID: 22261766
[TBL] [Abstract][Full Text] [Related]
40. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
